• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

结直肠癌中局部炎症反应的临床实用性。

The clinical utility of the local inflammatory response in colorectal cancer.

机构信息

Academic Unit of Surgery, School of Medicine, University of Glasgow, Glasgow Royal Infirmary, Glasgow, United Kingdom.

Academic Unit of Surgery, School of Medicine, University of Glasgow, Glasgow Royal Infirmary, Glasgow, United Kingdom.

出版信息

Eur J Cancer. 2014 Jan;50(2):309-19. doi: 10.1016/j.ejca.2013.09.008. Epub 2013 Oct 5.

DOI:10.1016/j.ejca.2013.09.008
PMID:24103145
Abstract

BACKGROUND

The host immune response is important in the prevention of tumour progression in solid organ cancers. The aim was to evaluate the clinical utility of the local inflammatory response in patients with colorectal cancer.

METHODS

Three hundred and sixty-five patients with primary operable colorectal cancer were included. The local inflammatory response was assessed using three different methods; (1) individual T-cell subtypes (CD3, CD8, CD45R0, FOXP3), (2) an immunohistochemistry-based immune score (Galon Immune Score) and (3) a histopathological assessment (Klintrup-Makinen grade). Relationships with tumour and host characteristics were established and the prognostic value of each method compared.

RESULTS

A strong infiltration of tumour infiltrating lymphoctyes (TIL's) was associated with improved cancer-specific survival. When individual T-cell subtypes were considered, CD3-positive cells were the strongest predictor of survival at the invasive margin (CD3(+) IM) while CD8-positive cells were the strongest predictor in the cancer cell nests (CD8(+) CCN). Infiltration of T-cells was related to early tumour stage, expanding growth pattern and lower levels of venous invasion but was not influenced by host characteristics or degree of systemic inflammation. In summary, CD3(+) IM, CD8(+) CCN, The Galon Immune Score and the Klintrup-Makinen grade all exhibited similar survival relationships in both node-positive and node-negative colorectal cancer.

CONCLUSION

A coordinated adaptive immune response is an important factor in predicting outcome in patients with primary operable colorectal cancer. By comparing different methodologies we have provided a foundation on which to develop a standardised approach for assessing the local inflammatory response in these patients.

摘要

背景

宿主免疫反应对于预防实体器官癌症的肿瘤进展至关重要。本研究旨在评估结直肠癌患者局部炎症反应的临床应用价值。

方法

纳入 365 例可手术治疗的原发性结直肠癌患者。采用三种不同方法评估局部炎症反应:(1)单个 T 细胞亚型(CD3、CD8、CD45RO、FOXP3),(2)基于免疫组化的免疫评分(Galon 免疫评分),(3)组织病理学评估(Klintrup-Makinen 分级)。评估肿瘤和宿主特征之间的关系,并比较每种方法的预后价值。

结果

肿瘤浸润淋巴细胞(TILs)的强烈浸润与癌症特异性生存相关。当考虑单个 T 细胞亚型时,浸润边缘的 CD3 阳性细胞(CD3(+) IM)是生存的最强预测因子,而肿瘤细胞巢中的 CD8 阳性细胞(CD8(+) CCN)是最强的预测因子。T 细胞浸润与早期肿瘤分期、扩展生长模式和较低的静脉侵犯程度相关,但不受宿主特征或全身炎症程度的影响。综上所述,CD3(+) IM、CD8(+) CCN、Galon 免疫评分和 Klintrup-Makinen 分级在有淋巴结转移和无淋巴结转移的结直肠癌中均显示出相似的生存关系。

结论

协调的适应性免疫反应是预测原发性可手术治疗结直肠癌患者预后的重要因素。通过比较不同的方法学,我们为评估这些患者局部炎症反应提供了一个标准化方法的基础。

相似文献

1
The clinical utility of the local inflammatory response in colorectal cancer.结直肠癌中局部炎症反应的临床实用性。
Eur J Cancer. 2014 Jan;50(2):309-19. doi: 10.1016/j.ejca.2013.09.008. Epub 2013 Oct 5.
2
The role of the in situ local inflammatory response in predicting recurrence and survival in patients with primary operable colorectal cancer.原位局部炎症反应在预测原发性可手术结直肠癌患者复发和生存中的作用。
Cancer Treat Rev. 2012 Aug;38(5):451-66. doi: 10.1016/j.ctrv.2011.09.001. Epub 2011 Sep 25.
3
CD3+ cells at the invasive margin of deeply invading (pT3-T4) colorectal cancer and risk of post-surgical metastasis: a longitudinal study.深度浸润性(pT3 - T4)结直肠癌浸润边缘的CD3 +细胞与术后转移风险:一项纵向研究
Lancet Oncol. 2009 Sep;10(9):877-84. doi: 10.1016/S1470-2045(09)70186-X. Epub 2009 Aug 3.
4
Infiltration of CD3⁺ and CD68⁺ cells in bladder cancer is subtype specific and affects the outcome of patients with muscle-invasive tumors.膀胱癌中CD3⁺和CD68⁺细胞的浸润具有亚型特异性,并影响肌层浸润性肿瘤患者的预后。
Urol Oncol. 2014 Aug;32(6):791-7. doi: 10.1016/j.urolonc.2014.02.007. Epub 2014 Apr 29.
5
Tumor-infiltrating FOXP3+ T regulatory cells show strong prognostic significance in colorectal cancer.肿瘤浸润性FOXP3 + T调节细胞在结直肠癌中显示出很强的预后意义。
J Clin Oncol. 2009 Jan 10;27(2):186-92. doi: 10.1200/JCO.2008.18.7229. Epub 2008 Dec 8.
6
Occurrence of tertiary lymphoid tissue is associated with T-cell infiltration and predicts better prognosis in early-stage colorectal cancers.三级淋巴组织的出现与 T 细胞浸润有关,并可预测早期结直肠癌的预后更好。
Clin Cancer Res. 2014 Apr 15;20(8):2147-58. doi: 10.1158/1078-0432.CCR-13-2590. Epub 2014 Feb 12.
7
Type, density, and location of immune cells within human colorectal tumors predict clinical outcome.人类结肠直肠癌肿瘤内免疫细胞的类型、密度和位置可预测临床结果。
Science. 2006 Sep 29;313(5795):1960-4. doi: 10.1126/science.1129139.
8
Identification of CD8+CD25+Foxp3+ suppressive T cells in colorectal cancer tissue.在结直肠癌组织中鉴定CD8+CD25+Foxp3+抑制性T细胞。
Gut. 2009 Apr;58(4):520-9. doi: 10.1136/gut.2008.158824. Epub 2008 Nov 20.
9
Tumor infiltration by T lymphocytes expressing chemokine receptor 7 (CCR7) is predictive of favorable outcome in patients with advanced colorectal carcinoma.T 淋巴细胞表达趋化因子受体 7(CCR7)浸润肿瘤可预测晚期结直肠癌患者的良好预后。
Clin Cancer Res. 2012 Feb 1;18(3):850-7. doi: 10.1158/1078-0432.CCR-10-3186. Epub 2011 Dec 5.
10
Intratumoural-infiltrating CD4 + and FOXP3 + T cells as strong positive predictive markers for the prognosis of resectable colorectal cancer.肿瘤内浸润的 CD4+和 FOXP3+T 细胞是预测可切除结直肠癌预后的强阳性预测标志物。
Br J Cancer. 2019 Oct;121(8):659-665. doi: 10.1038/s41416-019-0559-6. Epub 2019 Sep 6.

引用本文的文献

1
Investigating the Role of Tumor-Infiltrating Lymphocytes as Predictors of Lymph Node Metastasis in Deep Submucosal Invasive Colorectal Cancer: A Retrospective Cross-Sectional Study.探讨肿瘤浸润淋巴细胞作为深部黏膜下浸润性结直肠癌淋巴结转移预测指标的作用:一项回顾性横断面研究。
Cancers (Basel). 2023 Oct 31;15(21):5238. doi: 10.3390/cancers15215238.
2
Early-Onset/Young-Onset Colorectal Carcinoma: A Comparative Analysis of Morphological Features and Biomarker Profile.早发型/青年型结直肠癌:形态学特征与生物标志物谱的比较分析
Cureus. 2023 Jul 23;15(7):e42340. doi: 10.7759/cureus.42340. eCollection 2023 Jul.
3
Immune Response and Immune Checkpoint Molecules in Patients with Rectal Cancer Undergoing Neoadjuvant Chemoradiotherapy: A Review.
接受新辅助放化疗的直肠癌患者的免疫反应和免疫检查点分子:综述
Curr Issues Mol Biol. 2023 May 22;45(5):4495-4517. doi: 10.3390/cimb45050285.
4
High tissue expression of TLRs combined with high density of tumor infiltrating lymphocytes predicts a better prognosis in colorectal cancer patients.TLRs 高组织表达与肿瘤浸润淋巴细胞高密度预示结直肠癌患者预后较好。
PLoS One. 2023 Jan 17;18(1):e0280085. doi: 10.1371/journal.pone.0280085. eCollection 2023.
5
CD8 + T-cell Density Is an Independent Predictor of Survival and Response to Adjuvant Chemotherapy in Stage III Colon Cancer.CD8+T 细胞密度是 III 期结肠癌患者生存和辅助化疗反应的独立预测因子。
Appl Immunohistochem Mol Morphol. 2023 Feb 1;31(2):69-76. doi: 10.1097/PAI.0000000000001094. Epub 2022 Dec 13.
6
Expression Pattern and Prognostic Value of CTLA-4, CD86, and Tumor-Infiltrating Lymphocytes in Rectal Cancer after Neoadjuvant Chemo(radio)therapy.新辅助放(化)疗后直肠癌中CTLA-4、CD86及肿瘤浸润淋巴细胞的表达模式与预后价值
Cancers (Basel). 2022 Nov 14;14(22):5573. doi: 10.3390/cancers14225573.
7
Lag3: From Bench to Bedside.淋巴细胞活化基因3:从实验室到临床应用
Cancer Treat Res. 2022;183:185-199. doi: 10.1007/978-3-030-96376-7_6.
8
Comparison of Immune Response Assessment in Colon Cancer by Immunoscore (Automated Digital Pathology) and Pathologist Visual Scoring.免疫评分(自动化数字病理学)与病理学家视觉评分在结肠癌免疫反应评估中的比较
Cancers (Basel). 2022 Feb 24;14(5):1170. doi: 10.3390/cancers14051170.
9
Density of CD3 and CD8 Cells in the Microenvironment of Colorectal Cancer according to Prediagnostic Physical Activity.根据预测的体力活动,结直肠癌微环境中 CD3 和 CD8 细胞的密度。
Cancer Epidemiol Biomarkers Prev. 2021 Dec;30(12):2317-2326. doi: 10.1158/1055-9965.EPI-21-0508. Epub 2021 Oct 4.
10
Improving Risk Stratification of Early Oral Tongue Cancer with TNM-Immune (TNM-I) Staging System.使用TNM-免疫(TNM-I)分期系统改善早期口腔舌癌的风险分层
Cancers (Basel). 2021 Jun 29;13(13):3235. doi: 10.3390/cancers13133235.